Breastfeeding moms with malaria: do drugs reach baby?
NCT ID NCT05676645
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tracks how the malaria drug artemether-lumefantrine passes from a breastfeeding mother into her breastmilk and then into her nursing infant. Researchers will take blood and milk samples from 30 mother-infant pairs in Uganda over two weeks. The goal is to understand drug exposure in infants, which could lead to better dosing guidelines for breastfeeding women.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- artemether-lumefantrine
- What this could lead to
- If successful, this study could provide data to help doctors choose safe and effective malaria treatments for breastfeeding women and their babies.
- What could go wrong
- This is a small observational study (30 pairs) that only measures drug levels, not health outcomes. Results may not apply to other malaria drugs or regions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA,FALCIPARUM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Infectious Diseases Institute
Kampala, Kampala, 22418, Uganda
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental malaria vaccine aims to block parasite growth
- New malaria drug interaction study launches in healthy volunteers
- New malaria shots could replace daily pills
- New malaria antibody enters first human safety tests
- New malaria pill shows promise in early trial
- One shot to stop malaria? new injection tested in rwanda